Higher graft cell dose does not influence development of acute or chronic GVHD in haploidentical transplantation using PTCy

被引:0
作者
Nawas, Mariam T. [1 ,5 ]
Im, Annie [2 ]
Shaffer, Brian [3 ,4 ]
机构
[1] Univ Chicago Med, Dept Med, Hematopoiet Cellular Therapy Program, Chicago, IL USA
[2] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA
[4] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA
[5] Univ Chicago Med, Dept Med, Hematopoiet Cellular Therapy Program, 5841 S Maryland Ave, Chicago, IL 60637 USA
关键词
PERIPHERAL-BLOOD; STEM-CELLS; SURVIVAL; OUTCOMES;
D O I
10.1182/bloodadvances.2023010369
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:4475 / 4478
页数:4
相关论文
共 15 条
[1]   Severe Cytokine-Release Syndrome after T Cell-Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti-IL-6 Therapy Is Safe and Well Tolerated [J].
Abboud, Ramzi ;
Keller, Jesse ;
Slade, Michael ;
DiPersio, John F. ;
Westervelt, Peter ;
Rettig, Michael P. ;
Meier, Stephanie ;
Fehniger, Todd A. ;
Abboud, Camille N. ;
Uy, Geoffrey L. ;
Vij, Ravi ;
Trinkaus, Kathryn M. ;
Schroeder, Mark A. ;
Romee, Rizwan .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) :1851-1860
[2]   Peripheral-Blood versus Bone Marrow Stem Cells [J].
van Besien, Koen ;
Shore, Tsiporah ;
Cushing, Melissa .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (03) :287-288
[3]   High CD3+and CD34+peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation [J].
Czerw, Tomasz ;
Labopin, Myriam ;
Schmid, Christoph ;
Cornelissen, Jan J. ;
Chevallier, Patrice ;
Blaise, Didier ;
Kuball, Juergen ;
Vigouroux, Stephane ;
Garban, Frederic ;
Lioure, Bruno ;
Fegueux, Nathalie ;
Clement, Laurence ;
Sandstedt, Anna ;
Maertens, Johan ;
Guillerm, Gaelle ;
Bordessoule, Dominique ;
Mohty, Mohamad ;
Nagler, Arnon .
ONCOTARGET, 2016, 7 (19) :27255-27266
[4]   Impact of infused CD34+stem cell dosing for allogeneic peripheral blood stem cell transplantation with post-transplant cyclophosphamide [J].
Hany, Elmariah ;
Naqvi, Syeda Mahrukh Hussnain ;
Kim, Jongphil ;
Nishihori, Taiga ;
Mishra, Asmita ;
Perez, Lia ;
Faramand, Rawan ;
Lazaryan, Aleksandr ;
Liu, Hien D. ;
Khimani, Farhad ;
Nieder, Michael ;
Anasetti, Claudio ;
Pidala, Joseph ;
Bejanyan, Nelli .
BONE MARROW TRANSPLANTATION, 2021, 56 (07) :1683-1690
[5]  
Im A, 2020, Risk factors for graft-versus-host disease in haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide
[6]   Severe Cytokine Release Syndrome after Haploidentical Peripheral Blood Stem Cell Transplantation [J].
Imus, Philip H. ;
Blackford, Amanda L. ;
Bettinotti, Maria ;
Luznik, Leo ;
Fuchs, Ephraim J. ;
Huff, Carol Ann ;
Gladstone, Douglas E. ;
Ambinder, Richard F. ;
Borrello, Ivan M. ;
Fuchs, Robert J. ;
Swinnen, Lode J. ;
Wagner-Johnston, Nina ;
Gocke, Christian B. ;
Ali, Syed Abbas ;
Bolanos-Meade, F. Javier ;
Jones, Richard J. ;
Dezern, Amy E. .
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) :2431-2437
[7]   CD34+cell dose effects on clinical outcomes after T-cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (EBMT) [J].
Maffini, Enrico ;
Labopin, Myriam ;
Blaise, Didier ;
Ciceri, Fabio ;
Gulbas, Zafer ;
Deconinck, Eric ;
Leblond, Veronique ;
Chevallier, Patrick ;
Socie, Gerard ;
Araujo, Mercedes C. ;
Koc, Yener ;
Savani, Bipin N. ;
Gorin, Norbert C. ;
Lanza, Francesco ;
Nagler, Arnon ;
Mohty, Mohamad .
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (08) :892-899
[8]   Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation [J].
Martin, Paul S. ;
Li, Shuli ;
Nikiforow, Sarah ;
Alyea, Edwin P., III ;
Antin, Joseph H. ;
Armand, Philippe ;
Cutler, Corey S. ;
Ho, Vincent T. ;
Kekre, Natasha ;
Koreth, John ;
Luckey, John ;
Ritz, Jerome ;
Soiffer, Robert J. .
HAEMATOLOGICA, 2016, 101 (04) :499-505
[9]   Optimizing the CD34+cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation [J].
Mehta, Jayesh ;
Frankfurt, Olga ;
Altman, Jessica ;
Evens, Andrew ;
Tallman, Martin ;
Gordon, Leo ;
Williams, Stephanie ;
Winter, Jane ;
Krishnamurthy, Jairam ;
Duffey, Sara ;
Singh, Veerpal ;
Meagher, Richard ;
Grinblatt, David ;
Kaminer, Lynne ;
Singhal, Seema .
LEUKEMIA & LYMPHOMA, 2009, 50 (09) :1434-1441
[10]   CD3+graft cell count influence on chronic GVHD in haploidentical allogeneic transplantation using post-transplant cyclophosphamide [J].
Mussetti, A. ;
De Philippis, C. ;
Carniti, C. ;
Bastos-Oreiro, M. ;
Gayoso, J. ;
Cieri, N. ;
Pennisi, M. ;
Ciceri, F. ;
Greco, R. ;
Peccatori, J. ;
Patriarca, F. ;
Mariotti, J. ;
Castagna, L. ;
Corradini, P. .
BONE MARROW TRANSPLANTATION, 2018, 53 (12) :1522-1531